Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer worldwide, accounting for 5.5% of cases (I). Indeed, for parts of Asia and Africa, HCC accounts for almost 70% of cancer deaths (1) (2) . The main risk factors commonly associated with HCC progression include chronic viral hepatitis infection by hepatitis B or C, environmental poisoning by aflatoxins (particularly a risk factor in the developing world) and alcohol abuse leading to cirrhosis of the liver (I, [3] [4] . However, HCC is a highly malignant tumor, with a very poor prognosis. Survival rates average just one year following onset of symptoms. The diagnosis of HCC is histological. Many immunohistochemical (IHC) markers have been proposed to facilitate the diagnosis ofHCC. Although alone none ofthese are decisive, the combined use of several markers, for example pCEA, CD34 and HepParl, can be useful to differentiate benign from malignant liver lesions (5) .
Thioredoxins (Trx) are small ubiquitous proteins (12 kDa) that participate in various cellular processes via redox mediated reactions (6) . Trx catalyse thioldisulphide redox reactions by the reversible oxidation of the cysteine residues of the conserved active site WCGPC and are maintained in their active reduced form by the selenoenzyme Thioredoxin Reductase (TrxR) which uses the reducing power of NADPH, constituting the Thioredoxin system (6) (7) . Trxs are found in all living organisms from prokaryotic to eukaryotic cells. The Trx superfamily is expanding rapidly with several new members being characterised, however, these range from being true thioredoxins to proteins containing Trx-like domains. One such novel member of the Trx superfamily is ERdj5. ERdj5 is an Endoplasmic Reticulum (ER) resident protein comprised of a number of distinct domains, namely a DnaJ domain, three Protein Disulfide Isomerase (POI) like domains and one true Trx active site (8) . We have previously shown that ERdj5 interacts in an ATP-dependent manner with BiP (Immunoglobulin heavy chain-binding protein) and its expression is up-regulated upon treatment with ER stress inducers leading to the Unfolded Protein Response (UPR), thus suggesting a role for ERdj5 as an ER chaperone. The UPR encompasses a series of signal transduction cascades that become activated in the ER of eukaryotic cells when protein folding is disturbed by alterations in the ER lumen homeostasis (9) .
Roles for heat shock proteins Hsp70, Hsp27 and BiP as potential diagnostic markers in HCC, due to their over-expression in tumor tissue (4) and the over-expression of the thioredoxin system in many cancers, including HCC, has been well documented (10) (11) . We describe here the mc profile of Trx, TrxR and ERdj5 in HCC sections, all showing high over-expression specifically located to the tumor tissues. As much work has already focused on the role of the Thioredoxin system in cancer (12) , we decided to further investigate ERdj5 by studying the effect of Tunicamycin, ER stress inducer, and Doxorubicin, anthracycline chemotherapy drug, on a HCC derived cell line, HuH7, following treatment of the cells with small interfering RNAs for ERdj5.
MATERIALS AND METHODS

ERdj5 Antibody Production and affinity purification
Two peptide sequences of 14 amino acids were selected from within the ERdj5 human sequence [positions 102-116 (APVKYHGDRSKESLVC) and 640-654 (FYERAKRNFQEEQIN)] for peptide synthesis and immunisation (Agrisera, Sweden). Serum was affinity purified against both peptides.
Clinical Material
Ten paraffin blocks of liver biopsies from patients with viral hepatitis (C or B) and HCC were selected randomly from the archives of the Laboratory for Clinical Pathology, Karolinska University Hospital in Huddinge, Sweden, following approval from the regional ethical committee.
Immunohistochemical staining
In the IHC analysis, 3 urn tissue sections were deparaffinised in xylol and re-hydrated in decreasing concentrations of ethanol. Antigen retrieval was performed by 10 min heating of tissue sections in a microwave oven in 10 mM citrate buffer, pH 6.0. The automatic DAKO TechMate 500 was used for staining. Tissue slides were stained with primary antibody TrxRI (Upstate); 1:200, ERdj5; 1:500; Trx I (IMCO); I: 100, diluted in ChemMate antibody diluent (DakoCytomation), for 25 min at room temperature. Endogenous peroxidase was blocked with ChemMate peroxidase blocking solution (DakoCytomation). For visualization ChemMate Detection Kit Peroxidase/DAB (DakoCytomation) was used. As a secondary antibody for Trx I, biotinylated rabbit anti-goat (DakoCytomation) was used (I :500). Tissue sections were counterstained with haematoxylin. The specificity of the primary antibody reaction was confirmed by pre-incubation for I hour of the antibody with the specific antigen before staining.
Mathematical determination of positivity in immunohistochemical stainings
Using the HSI (Hue Saturation and Intensity) mathematical model (13) , the saturation of a given colour was used to compare different degrees of positivity of the immunohistochemical stain. The method consisted of the following steps: a) selection of the degree range of the colour in question (in our case brown, in the range 30°-45°) and b) measurement of the saturation of the Hue range in the histological samples and controls (Scale 0-I). The software used was created by one of the authors (A.e.) and it is part of the software currently used at the image analysis core facility of the Department of Pathology, Karolinska University Hospital/Karolinska Institutet, Stockholm (14) . Results were analysed using the STATISTICA software.
ERdj5 siRNA oligo synthesis and transfection siRNA oligos for ERdj5 were generated according to the manufacturers' instructions using the ShortCut RNAi Kit (New England Biolabs, InVitro, Sweden). Briefly, a 386bp fragment from the open reading frame of ERdj5 was cloned into the pLITMUS 38i plasmid. dsRNA and RNA oligos were prepared according to the manufacturers' protocol for generation of siRNA mixes of ERdj5. HuH7 cells were maintained in DMEM, supplemented with Pencillin and Streptomycin and 10% Foetal bovine serum at 5% CO 2 at 37°C. Cells were split 24 h before transfection to have 40-50% confluency on the day of transfection. 25 nM of ERdj5 siRNA and control siRNA mixes were transfected using TransPass RI transfection reagent (New England Biolabs, InVitro, Sweden) according to the manufacturers' instructions
RNA preparation, cDNA synthesis and Real Time rc« analysis
Total RNA was extracted from cells 48 hours post transfection, using the RNAeasy kit (QIAGEN, Sweden) and purified according to kit instructions. RNA was treated with Dnase I and eDNA was synthesised using Superscript III according to the manufacturers' instructions (Invitrogen, Sweden). Two specific primer pairs for ERdj5 were designed using the Primer Express software (PE Biosystems), namely ERdj5-RT-FI (GGACATCACTCTGCTGAACAAATC), ERdj-RT-RI (TCGTTGAAGGTGGTGGGTGT), ERdj5-RT-F2 (GC AAGCAGTAGAGAAATAAGACAAGCT), ERdj5-RT-R2 (CGCCATGTGCATTTGGG), with GAPDH primers used as controls. Analysis of all genes was carried out using the SYBR green detection system using Applied Biosystems 7500 real-time PCR machine and reagents.
Doxorubicin and Tunicamycin treatments of siRNA transfected HuH7 cells
Control and ERdj5 siRNA HuH7 cells were seeded to 96 well plates prior to treatments. Following adhesion of cells, plates were treated with either Doxorubicin (Pharmacia & Upjohn, Stockholm Sweden) at 0.5 and 1 ug/ml or Tunicamycin (Sigma, Stockholm, Sweden) with a final concentration range of 1 and 1.5 ug/ml, Cells were returned to the incubator for a further 16 hours. Following incubation, cell viability was assessed using the XTT assay according to the manufacturers' instructions (Roche, Sweden). P values were calculated using the Student t-test.
RESULTS
Immunohistochemistry ofHuman Hepatocellular Carcinoma Sections
To investigate the expression of members of the thioredoxin superfamily in human HCC sections, we selected at random 10 cases of HCC from archived paraffin embedded material. Using antibodies for Trxl, TrxRI and ERdj5, we determined the expression patterns for each protein (Fig. I) . The expression levels were elevated for all three proteins in the tumor cells. In the case of ERdj5, there was very high expression compared to internal control specifically located to the cytosol of the tumor cells of all patient cases. To measure and compare the different degrees of positivity of the expression patterns of the thioredoxin family proteins, we developed a system based on the evaluation of the saturation of the IHC staining of the tumor tissue compared to the non-tumor tissue of the same section (14) . Comparisons within the same sections are the ideal internal control as both were treated exactly the same throughout the entire process from fixation to staining. IHC using ERdj5 antibodies showed a much larger increase in saturation (Fig.  2) compared to TrxRl and Trxl antibody staining following subtraction of internal control for each section, which confirmed our observations during microscopic examination of the sections.
Effect ofER stress and chemotherapeutic agents on HuH? cells transfected with small interfering RNA/or ERdj5
Using a cell line derived from HCC, HuH?, we transfected cells with siRNA oligo mix for both ERdj5 and control and subsequently treated the cells with Tunicamycin and Doxorubicin. Initially, we tested the ERdj5 siRNA system in a number of cell lines including HuH? to optimise conditions for knockdown of the gene and to determine the level of knockdown of the gene compared to the control siRNA ( Fig. 3) . Quantitative Real-Time PCR analysis of HuH? cells transfected with siRNA control and ERdj5 mixes, showed a decrease of approximately 65% in the levels of ERdj5 compared to untransfected cells and cells transfected with the control siRNA mix.
To study the effect ofER stress and DNA damage on ERdj5 knockdown cells, HuH? cells were initially transfected with control and ERdj5 siRNA oligo mixes. Two days post-transfection, the cells were treated with differing concentrations oftunicamycin. Using a cell viability assay, our results showed that following incubation with tunicamycin, control cells were more vulnerable to cell death by ER stress (Fig. 4A) .' . . .
Non tumor Tumor
ERdjS TrxRl Trxl Fig, 1 . Immunohistochemistry ofHuman Hepatocellular carcinoma biopsy sections using antibodies against ERdj5. TrxI and TrxRI . Tumor and non-tumor images were captured from the same section oftissue. The negati ve control involved pre-incubation of the antibodies with its particular antigen prior to staining to establish the specificity of the antibodies.
treating HuH7 cells with varying concentrations of Doxorubicin, which induces DNA damage, gave the opposite effect. Here (Fig. 48 ), the cells with low levels of ERdj5 were more susceptible to cell death than the control cells (p<O.O I).
DISCUSSION
Hepatocellular carcinoma is an aggressive malignanc y with a poor prognostic outlook ( 15) . The diagnosi s is essentially histological, and even if IRC can facilitate the diagnosis in difficult cases, no single antibod y is conclu sive. Therefore, we thought it interesting to investigate if members of the Thioredoxin superfamily were over-expressed in the tumor cells of HCC cases and whether these proteins had a diagnostic value in such cases. Using archived patient material from an HCC tissue bank , we randomly selected ten cases to examine for Trx1, TrxRI and ERdj5 expression. These biopsy materials were collected over a number of years and had been subjected to different conditions, e.g. fixation times etc., and archived, not specifically for this study. Thus, the non-tumorous tissue of each biopsy served as the ideal internal control as this tissue had been subjected to the exact same processing, storage and staining as the tumorou s tissue. Our study promotes these members of the Thioredoxin superfamily as IRC markers to specifically label the tumor cells, with ERdj5 showing most potential as a tumor marker, with a pronounced contrast to the surrounding nontumor tissue, in all cases examined. Furthermore, using a Hue saturation evaluation system developed in our laboratory, which determines and compares the different degrees of positivity of the expression of the proteins under investigation, we showed that all protein s exhibited higher expression levels in the tumor tissue compared to the non-tumor tissue of the same section, with ERdj 5 showing a much higher degree of positivi ty than Trxl or TrxR!.
As our IRC findings show such high expression of ERdj5 and TrxRI in the HCC tumor cells, we decided to further investigate whether these protein s had a role in the well known resistant phenotype of these tumors. However, previous studies have very thoroughly investigated TrxRs in cancer and in particular HCC (10) (11) 16) . Numerous findings have shown an over-expression ofTrxRs in human tumors (10) and further investigated the inhibitory effect of TrxR in HCC cells using TrxR antisense RNA. These previous studies show that TrxR antisense could significantly reduce the TrxR mRNA activity and suppress the growth of SMMC-772 1 HCC cells (11) . In addition, Gan et al. showed that TrxR antisense RNA could significantly increase p53 mRNA levels and decrease Bcl-2 mRNA levels, concluding that TrxR antisense RNA did have an inhibitory effect on the cell growth (11) . Therefore, we thought it interesting to investigate ERdj5 using siRNA in HCC as no published results existed showing the effects of knocking down the mRNA levels ofERdj5 in mammalian cancer cells. Using a cell line derived from human hepatocellular carcinoma, HuH7 , we established a siRNA system for ERdj5, giving a knockdown of approximately 65% compared to control. We designed a study to determine the effects of exerting ER stress in these cells . Tunicamycin inhibits Nlinked glycosylation of newly synthesised proteins and has been shown to induce programmed cell death in mammalian cells by stimulating ER stress (17) . Our previous work proved that ERdj5 is an UPR gene using a panel of ER stress inducers , including tunicamycin (8) . We tested HuH7 cells with varying concentrations of tunicamycin and determined that the levels of ERdj5 increase in this cell line following the addition of tunicamycin. Thus, by treating with tunicamycin, we elicited an ER stress leading to activation of the UPR in the HuH7 cells (data not shown). Our data here show that control cells, with normal levels of ERdj5, were more susceptible to cell death than cells with lower levels ofERdj5 when undergoing ER stress. We can therefore consider that ERdj5 could have a role in apoptosis in ER stressed cells as prolonged exposure to ER stress leads to apoptosis (18) . Evidence exists, however, showing that activation of the UPR might protect cells from apoptosis (19) . It still remains unclear whether activation of the UPR is of benefit for the host or the tumor. Activation of the UPR can occur in tumors, due to a restricted supply of oxygen and nutrients, thus affecting protein folding in the ER. Several studies suggest that activation of the UPR could have an important role in tumor growth (19) . However, tumor cells can become resistant to apoptosis through the expression of anti-apoptotic proteins or through the mutation or down-regulation of pro-apoptotic proteins, which may be an essential feature of cancer development (20) Recent studies have researched ER stress and chemotherapeutic agents, namely topoisomerase II targeting agents, outlining ER stress induced protection against these agents (19, 21) . We therefore thought it interesting to investigate the effect of Doxorubicin, a topoisomerase II inhibitor and a chemotherapeutic drug used in the treatment of HCC, in our ERdj5 knockdown system. Intriguingly, the Doxorubicin treatment of ERdj5 knockdown and control cells showed that the cells with lower levels of ERdj5 were more vulnerable to cell death than control cells, indicating a role for ERdj5 in the resistance of HCC cells against cell death from Doxorubicin. Previous studies have shown that the ER chaperone BiP (21) can protect cells against cell death resulting from disturbance of ER homeostasis. However, studies have shown that over-expression ofBiP could have an anti-apoptotic property, leading to cancer progression and drug resistance (21) (22) , and BiP has also been shown to be over-expressed in HCC (4). From our IHC results, we clearly see an over-expression of ERdj5 and, coupled with the data showing a resistance of control cells over knockdown ERdj5 cells to Doxorubicin, it is interesting to speculate that ERdj5 could also have an anti-apoptotic function, similar to its co-chaperone BiP, and could also perform a role in resistance to topoisomerase II poisons.
Taken together, the findings presented here could provide some insight on the process ofcarcinogenesis and the development ofdrug resistance in tumor cells. Yet, at present the molecular mechanisms behind HCC remain unclear. Current strategies for diagnosis involve the monitoring of patients who fall into the risk categories defined by earlier research. Thus, the ideal biomarker should be specific and predict at an early stage whether the patient will develop HCC, and importantly, should provide crucial knowledge of the mechanism of tumor development. Our data promote members of the thioredoxin superfamily as potential histological markers for HCC. A more extensive study is in progress to examine the potential of these redox proteins as markers, and will also categorise HCC cases with different aetiology and differentiation. Interestingly, ERdj5 is expressed in highly proliferative epithelium such as in small intestine, colon and bone marrow (Cunnea P, Spyrou G unpublished observations) and thus could be a marker of proliferative activity. Furthermore, our investigations into ERdj5 propose a possible role for this protein in drug resistance and in the ER stress response in tumors. Extensive research is required to delineate the role of the ER stress response in cancer and to discover novel targets to aid in its early diagnosis, intervention and prognosis.
